“antibodies” Archives

in
Entry Author Date Location
Led by Gilead Veteran Riva, Glenmark’s Ichnos Steps Out on Its Own 10/15/19 New York
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome 06/26/19 Boulder/Denver
Washington VC Watch: Pattern Computer, Chatbox, Joylux & More 04/30/19 Seattle
Invenra, Madison Firm Developing Therapeutic Antibodies, Adds $7.1M 10/19/18 Wisconsin
Alector Snags $133M to Activate Immune Cells Against Neurodegeneration 07/25/18 San Francisco
Invenra Partners with Exelixis to Develop New Antibody Cancer Drugs 05/03/18 Wisconsin
Invenra, Developer of Therapeutic Antibodies, Raises $2.9M 10/05/17 Wisconsin
Invenra Signs On With Merck in Antibody Discovery Partnership 07/28/17 Wisconsin
Gates Foundation Leads $45.5M Round for Gerngross’s Biotech Arsanis 04/26/17 Boston
Invenra Raises $3M to Develop Antibodies with, and for, Drug Makers 07/20/16 Wisconsin
Racing Zika: For Every Short Cut, There’s An Open Question 03/15/16 National
Ensemble Quietly Amasses Cancer Drug Pipeline, Scouts for New Deals 03/08/16 Boston
InCube Labs Startup Fe3 Plans Iron-Delivering Patch For Anemia 03/04/16 Texas
Adicet Joins the Immunotherapy Fray With $51M and Mystery Cells 01/27/16 San Francisco
No Drug Yet In Clinic, But CytomX Raises $80M In Discounted IPO 10/08/15 San Francisco
Avitide Gets $7.6M More to Purify Complex Biologics 08/06/15 Boston
Sanofi, Regeneron Set Sights on Immuno-Oncology With New $2B+ Pact 07/28/15 New York
Bluebird Adds to CAR-T Arsenal With Five Prime Antibody Deal 05/26/15 Boston
Moderna Forms Latest Venture, Valera, to Fight Infections With mRNA 01/08/15 Boston
Diagnosis On-demand: Methodist Develops V-chip Medtech Device 04/11/14 Texas
Tillman Gerngross, the Scientist Turned Scientific Businessman 01/09/14 Boston
Seattle Genetics Nabs $25M More From AbbVie for Souped Up Antibodies 01/08/14 Seattle
PharmAthene Backs Out of Theraclone Sciences Merger 12/02/13 Seattle
iPierian Nabs $30M To Keep Alzheimer’s, Autoimmune Drugs Moving 09/04/13 San Francisco
Adimab Teams Up With Celgene, Innovent, in Latest Partnership Deals 08/20/13 Boston
Celgene Emerges as Biotech’s Shrewdest, Nimblest Dealmaker 08/05/13 National
Theraclone Merges With PharmAthene, Plans to Stay in Seattle 08/01/13 Seattle
Adimab Turns Cash Flow Positive With GSK, Biogen Tech Transfer Deals 07/26/13 Boston
Applying “Innovation Arbitrage” to Develop Novel Medicines in China 05/28/13 San Diego
Memorial Sloan-Kettering and Eureka Go After ‘Undruggable’ Targets 03/21/13 New York
Page 1 of 5 next page »